You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Minimum residual disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Minimal Residual Disease Using Multi-omics Approach

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023

Minimally Residual of Esophageal Cancer 001

Recruiting
  • Esophageal Carcinoma
  • Minimal Residual Disease
    • Shijiazhuang, Hebei, China
      Fourth Hospital of Hebei Medical University
    Jul 17, 2023

    Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab injection
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 20, 2023

    AML, Adult, Minimal Residual Disease Trial (MRD assessment)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • MRD assessment
    • (no location specified)
    Oct 13, 2023

    HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

    Not yet recruiting
    • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
    • (no location specified)
    Nov 7, 2023

    B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

    Recruiting
    • B-Cell Lymphoblastic Leukemia
    • Acute Lymphoblastic Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2023

    Digital Droplet PCR in Early Period After Allo-HSCT to Predict

    Completed
    • Measurable Residual Disease
    • Digital Droplet PCR
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Aug 17, 2023

    GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE

    Enrolling by invitation
    • Pancreatic Adenocarcinoma
    • liquid biopsy
    • Stockholm, Sweden
      Gastrocentrum, KarolinskaUniversity Hospital
    Oct 26, 2023

    Next-generation Sequencing in Pediatric B-ALL Children Patients

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • (no location specified)
    Apr 19, 2023

    Drug Exposure and Minimum Inhibitory Concentration in Treatment

    Not yet recruiting
    • Mycobacterium Avium Complex
    • +3 more
    • Drug exposure
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Apr 10, 2023

    Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jan 10, 2023

    Measurable Residual Disease in Acute Myeloid Leukemia as

    Terminated
    • Leukemia, Myeloid, Acute
    • Measurable residual disease measured by flow cytometry
    • Heidelberg, BW, Germany
      University Hospital Heidelberg
    Sep 12, 2022

    Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease, Elderly Patients Trial in Beijing (colchicine)

    Not yet recruiting
    • Percutaneous Coronary Intervention
    • +3 more
    • Beijing, Beijing, China
      Fuwai Hospital, National Center for Cardiovascular Diseases, CAM
    Sep 1, 2023

    Minimal Residual Disease Trial in Tianjin (QN-030a, Cyclophosphamid, Fludarabine)

    Recruiting
    • Minimal Residual Disease
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 3, 2022

    MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

    Not yet recruiting
    • Multiple Myeloma
    • Minimal Residual Disease
      • (no location specified)
      Nov 1, 2023

      Heathy Women, Pre Menopausal Age, Exlution Criteria: Pregnant Women; Known Gastrointestinal Disorder; Abnormal Liver or Kidney

      Completed
      • Heathy Women
      • +6 more
      • Jarlsberg cheese
      • Skjetten, Skedsmo, Norway
        Skjetten Legesenter
      Jan 10, 2023

      Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)

      Recruiting
      • Stage II-III Gastric Cancer
      • MRD-guided therapy
      • Jinan, Shandong, China
      • +4 more
      Nov 27, 2023

      Residual Disease in Breast Cancer Remission After Primary

      Recruiting
      • Breast Cancer
      • minimally invasive preoperative image-guided vacuum-assisted biopsy
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Jul 10, 2023

      Obstructive Sleep Apnea Syndrome With Residual Excessive Daytime

      Recruiting
      • Sleep Apnea Syndromes
      • Treatment
      • Oggebbio, Italy
        Istituto Auxologico Italiano
      Mar 21, 2023

      Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

      Recruiting
      • Brain Metastases
      • Non-small Cell Lung Cancer
      • EGFR-TK Inhibitor
      • Stereotactic radiotherapy
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 27, 2023

      Mixed Phenotype Acute Leukemia (MPAL), Measurable Residual Disease (MRD) Trial in Baltimore (BLINCYTO (Blinatumomab))

      Recruiting
      • Mixed Phenotype Acute Leukemia (MPAL)
      • Measurable Residual Disease (MRD)
      • BLINCYTO (Blinatumomab)
      • Baltimore, Maryland
        Greenebaum Cancer Center at University of Maryland Medical Cente
      Apr 18, 2022

      Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)

      Recruiting
      • Pancreatic Cancer
      • +2 more
      • Later-line therapy
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Apr 10, 2023

      AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

      Not yet recruiting
      • AML, Adult
      • Minimal Residual Disease
      • CD33/CLL1 dual CAR-NK cell
      • +5 more
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Aug 4, 2023

      Pancreatic Cancer, Resectable Carcinoma Trial in Beijing (Later-line therapy)

      Recruiting
      • Pancreatic Cancer
      • Resectable Carcinoma
      • Later-line therapy
      • Beijing, China
        Department of Medical Oncology, Peking Union Medical College Hos
      Apr 10, 2023

      Danish Assessment of Minimal Residual Disease by Liquid Biopsies

      Recruiting
      • Colorectal Neoplasms
      • +5 more
        • Copenhagen, Capital Region Of Denmark, Denmark
        • +8 more
        Oct 13, 2023